Fox-Roku’s $22B Deal, A New Nasdaq Biotech And A $25B Chemicals Tie-Up: Deals Investors Are Watching
Three major deals involving Fox and Roku, InMed Pharmaceuticals and Mentari Therapeutics, and AkzoNobel and Axalta are in focus this week. On Friday, Fox completed its $22 billion acquisition of Roku in a major streaming bet. Last week, InMed Pharmaceuticals completed its merger with privately held Mentari Therapeutics and is expected to start trading on … Read more